“For all who suffer from Arthritis, Rheumatism, Arterio-Sclerosis, Renal and Bilious Lithiasis, Headache, Gout, Gravel, Lumbago, Sciatic Pains, Neuralgia and all uric acid troubles.” “In fact, Urodonal is five times more active than piperazine, and thirty-seven times more active than lithia. We are, therefore, entitled to say that no other eliminator of uric acid can be compared with it.” “Being _37 times more active than lithia_, it clears the heart valves of any sandy substances which may clog them, and checks the atheromatous degeneration of the blood vessels.” These extracts indicate sufficiently the extravagant tone of the advertising (Rule 6): None of the ingredients are notably active in dissolving uric acid when administered by mouth. None produce any marked increase of uric acid elimination. No intelligent physician would use a uric acid solvent for “bilious lithiasis”; and their usefulness in the other conditions is open to doubt, to put it mildly. Although the preparation is a simple mixture, the name does not indicate the components, but inclines to therapeutic suggestion (Rule 8). Nothing is to be gained by combining several drugs which are useless, severally, for the purpose intended, as in the present case (Rule 10). Urodonal is marketed under inconsistent statements of composition and with exaggerated therapeutic claims; the name is nondescriptive and the mixture is unscientific. The Council decided that the preparation should be declared ineligible for conflict with Rules 1, 4, 6, 8 and 10 and that this report should be published.--(_From The Journal A. M. A., Aug. 14, 1915._) FORMAMINT Report of the Council on Pharmacy and Chemistry The following report has been authorized for publication. W. A. Puckner, Secretary. Formamint is a proprietary medicine manufactured by the A. Wulfing Company (New York, London and Berlin), which is affiliated with the Bauer Chemical Company. It has been widely advertised in Europe for several years, and is now on the American market;[14] it is advertised in this country both in newspapers and medical journals. [14] The Journal A. M. A., Feb. 24, 1912, p. 572. Following is a brief review of the more important alleged investigations that have been reported from time to time in various European journals.